Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (118)

« Back to Publications

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

Christou EE. et al, (2026), Retina, 46, 272 - 280

novel EYS c.6192-1G>A variant presents ideal base editing therapeutic opportunities.

Kaukonen M. et al, (2026), Ophthalmic Genet, 1 - 4

Special AAO Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2025 Revision).

Marmor MF. et al, (2025), Ophthalmology

XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa

MacLaren RE. et al, (2025), Ophthalmology Science, 5, 100595 - 100595

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom.

Yusuf IH. et al, (2024), Eye (Lond), 38, 2796 - 2804

ssessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study

Lam BL. et al, (2024), Ophthalmology, 131, 1083 - 1093

Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study

Yusuf IH. et al, (2024), Eye, 38, 43 - 44

Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study

Yusuf IH. et al, (2024), Eye, 38, 28 - 30

Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial

Yusuf IH. et al, (2024), Eye, 38, 35 - 36

Infographic: A randomized trial of immediate vitrectomy and of intravenous antibiotics for postoperative bacterial endophthalmitis: the endophthalmitis vitrectomy study

Yusuf IH. et al, (2024), Eye, 38, 21 - 23

Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study

Yusuf IH. et al, (2024), Eye, 38, 26 - 27

Infographic: Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study

Yusuf IH. et al, (2024), Eye, 38, 31 - 32

Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study

Yusuf IH. et al, (2024), Eye, 38, 33 - 34

Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy Study

Yusuf IH. et al, (2024), Eye, 38, 24 - 25

Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S

Yusuf IH. et al, (2024), Eye, 38, 37 - 38

Load More

1
2
3
4
5
6
7
...
»